STRO — SUTRO BIOPHARMA INC

Ownership history in Aberdeen Group plc  ·  8 quarters on record

This page tracks every 13F SEC filing in which Aberdeen Group plc reported a position in SUTRO BIOPHARMA INC (STRO). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 UNCHANGED 69,389 — 0% 0.00% $60K $8.70
2025 Q2 UNCHANGED 69,389 — 0% 0.00% $50K $7.10
2025 Q1 UNCHANGED 69,389 — 0% 0.00% $45K $6.50
2024 Q4 UNCHANGED 69,389 — 0% 0.00% $128K $18.40
4 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    STRO price (monthly, adj. close)

Other funds also holding STRO

As of 2025 Q4 — sorted by position size

Velan Capital Investment Management LP 3Y 2.09% ACUTA CAPITAL PARTNERS, LLC 3Y 7Y 0.53% Affinity Asset Advisors, LLC 3Y 0.49% Kynam Capital Management, LP 3Y 0.35% Opaleye Management Inc. 3Y 7Y 0.29% Samsara BioCapital, LLC 3Y 7Y 0.24% Eversept Partners, LP 3Y 7Y 0.11% Vestal Point Capital, LP 0.1% GSA CAPITAL PARTNERS LLP 3Y 7Y 0.09% TANG CAPITAL MANAGEMENT LLC 3Y 7Y 0.08%
← Back to Aberdeen Group plc Holdings